About Roka Bio Science
Roka Bio Science is a publicly listed company based in Lake Forest (United States) founded in 2009. Food pathogen detection assays using ribosomal RNA targeting are provided. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Roka Bio Science has raised $109.5 million across 5 funding rounds from investors including TPG, Orbimed and Aisling Capital. The company has 88 employees. Roka Bio Science offers products and services including Atlas® System, Atlas E. coli O157:H7 EG2 Detection Assay, and Atlas Salmonella SEN Detection Assay. Its focus areas include Healthcare, Biotechnology and Food Safety Testing. Its legal entity is Roka Bioscience, Inc.
Company details
Roka Bio Science is engaged in developing advanced molecular technologies for food pathogen detection. Solutions are provided for various sectors including beef, dairy, poultry, pet food, produce, ready-to-eat foods, spices, and environmental testing. The companys core technologies, such as Target Capture and Transcription-Mediated Amplification, are integrated into the Atlas System and detection assays. These solutions are designed to offer automated, sensitive, and rapid testing for pathogens like E. coli, Salmonella, and Listeria. Services and products are tailored to enhance food safety standards across multiple industries.
- Headquarters Lake Forest, United States
- Employees 88
- Stage Public
- SectorsConsumer
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website rokabio.com
- Social LinkedIn
- Legal Name Roka Bioscience, Inc.
- Annual Revenue$7.24 M (USD)21as on Dec 31, 2016
- Net Profit-$30.79 M (USD)16as on Dec 31, 2016
- EBITDA-$29.48 M (USD)16as on Dec 31, 2016
- Total Equity Funding$109.5M (USD)
in 5 rounds
- Latest Funding Round$22.5M (USD), Post-IPO
Sep 2016
- InvestorsTPG
& 4 more
- Employee Count88
Products & Services of Roka Bio Science
Roka Bio Science offers a comprehensive portfolio of products and services, including Atlas® System, Atlas E. coli O157:H7 EG2 Detection Assay, and Atlas Salmonella SEN Detection Assay.
Automated system for detecting pathogens in food samples.
Assay designed for detecting E. coli in food.
Assay used for identifying Salmonella in food products.
Funding Insights of Roka Bio Science
Roka Bio Science has successfully raised a total of $109.5M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $22.5 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $109.5M
- Total Rounds 5
- Last Round Post-IPO — $22.5M
- First Round $20M
(Jul 2011)
- Investors Count 5
All 5 funding rounds of Roka Bio Science with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $22.5M | Post-IPO | – | – | – |
| Dec 2013 | $17M | Series E | – | – | – |
| Jun 2013 | $25M | Series E | – | – | – |
| Jan 2012 | $47.5M | Series D | – | Aisling Capital | |
| Jul 2011 | $20M | Series C | – | Orbimed, New Enterprise Associates | – |
5 investors in total: 5 institutional.
Investors in Roka Bio Science
Roka Bio Science has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include TPG, Orbimed and Aisling Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in the US | aislingcapital.com | New York, United States | ||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Provides clinical diagnostics, blood screening, and research products. | 1996 | gen-probe.com | San Diego, United States |
Investor details for Roka Bio Science
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Roka Bio Science
5 people are tracked at Roka Bio Science (3 in leadership, 2 in team); the tracked headcount is 88.
| Name | Role | Group |
|---|---|---|
Thomas Smith | CEO | Leadership |
Kenna Huff | Director Of Operations | Leadership |
Lauretta Johnson | Senior Director, Business Development | Leadership |
Christine Szczecina | Senior Accts. Receivable, Credit And Collection Specialist | Team |
Clifford Haight | Mechanical Process Engineer | Team |
Complete people profiles for Roka Bio Science
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Roka Bio Science
4 dated milestones of Roka Bio Science across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Roka Bio Science is founded.
- Funding First funding round of $20.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $22.5M.
Web traffic of Roka Bio Science
The website of Roka Bio Science (rokabio.com) receives about 4.2K visits a month and ranks #4,841,750 among all websites worldwide, #5,685 in Biotechnology and Pharmaceuticals.
- Monthly visits4.2K
▲ 18.6% vs previous month
- Unique visitors1.5K
per month
- Global rank#4,841,750
among all websites
- Category rank#5,685
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.7
- Average visit25 sec
- DevicesDesktop 22% · Mobile 78%
Websites whose visitors overlap most with Roka Bio Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cempra.com | 100% | View details |
Top companies in Food Processing
3 companies that operate in the same segment as Roka Bio Science (Food Processing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering refrigerated pet food | 2006 | Secaucus, New Jersey, United States | USD 54 M | USD 1.1 B | 1,300 | |
Coffee, tea, and extract beverage solutions are provided globally. | 2009 | North Little Rock, Arkansas, United States | USD 17 M | USD 1.19 B | 1,410 | |
Multi-category food products are produced and distributed globally. | 1866 | Minneapolis, Minnesota, United States | USD 18.42 B | 33,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Roka Bio Science
Roka Bio Science was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Roka Bio Science is headquartered in Lake Forest, United States. It is registered at Lake Forest, California, United States.
Roka Bio Science is a funded company, having raised a total of $109.5M across 5 funding rounds to date. The company's 1st funding round was a Series C of $20M, raised on Jul 2011.
Roka Bio Science has 88 employees.
Annual revenue of Roka Bio Science is $7.24M as on Dec 31, 2016.
Roka Bio Science is engaged in developing advanced molecular technologies for food pathogen detection. Solutions are provided for various sectors including beef, dairy, poultry, pet food, produce, ready-to-eat foods, spices, and environmental testing. The companys core technologies, such as Target Capture and Transcription-Mediated Amplification, are integrated into the Atlas System and detection assays. These solutions are designed to offer automated, sensitive, and rapid testing for pathogens like E. coli, Salmonella, and Listeria. Services and products are tailored to enhance food safety standards across multiple industries.
Roka Bio Science offers Atlas® System, Atlas E. coli O157:H7 EG2 Detection Assay, and Atlas Salmonella SEN Detection Assay.
Roka Bio Science has 5 investors. Key investors include TPG, Orbimed, Aisling Capital, NEA, and Gen-Probe.
Roka Bio Science operates through Roka Bioscience, Inc..